Publication: Hepatitis B and NAFLD: Lives Crossed.
No Thumbnail Available
Identifiers
Date
2017
Authors
Morales, Maria L
Sendra, Carmen
Romero-Gomez, Manuel
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Asociacion Mexicana de Hepatologia
Metrics
Export
Abstract
Hepatitis B virus infection seems to protect against steatosis and insulin resistance decreasing NAFLD. Metabolic syndrome has been associated with increased risk of disease progression to cirrhosis and liver cancer in hepatitis B. HBsAg seroclearance increased over time and it could be a confounding factor when analysing NAFLD and hepatitis B prevalence.
Description
MeSH Terms
Hepatitis B
Hepatitis B Surface Antigens
Hepatitis B virus
Hepatitis B, Chronic
Humans
Non-alcoholic Fatty Liver Disease
Hepatitis B Surface Antigens
Hepatitis B virus
Hepatitis B, Chronic
Humans
Non-alcoholic Fatty Liver Disease
DeCS Terms
Hepatitis B
Enfermedad del hígado graso no alcohólico
Fibrosis
Neoplasias Hepáticas
Resistencia a la insulina
Antígenos de superficie de la hepatitis B
Enfermedad del hígado graso no alcohólico
Fibrosis
Neoplasias Hepáticas
Resistencia a la insulina
Antígenos de superficie de la hepatitis B
CIE Terms
Keywords
HBeAg, HBsAg, Hepatitis B, NAFLD, NASH
Citation
Morales MR, Sendra C, Romero-Gomez M. Hepatitis B and NAFLD: Lives Crossed. Ann Hepatol. 2017 March-April;16(2):185-187.